Mrs. Janet M Gibbons, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 171 Intrepid Ln, Syracuse, NY 13205 Phone: 315-437-4689 Fax: 315-437-4698 |
Anya Freedman-doan Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3175 E Genesee St Ste 5, Syracuse, NY 13224 Phone: 315-810-2423 |
Ms. Jacqueline Ann Caughey Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 Harrison St, Syracuse, NY 13210 Phone: 315-435-4204 |
Ms. Sujini Ramachandar, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1744 W Genesee St, Syracuse, NY 13204 Phone: 315-468-3414 Fax: 315-468-2089 |
Ms. Sharon Schneider Pollock, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Audiology And Speech Pathology (126), Syracuse, NY 13210 Phone: 315-425-4400 Fax: 315-425-2440 |
Mrs. Beatriz Rholyn Nalli, M.S., CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 171 Intrepid Ln, Syracuse, NY 13205 Phone: 315-437-4689 |
Maureen Ann Robinson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1951 Caleb Ave, Syracuse, NY 13206 Phone: 315-218-7444 Fax: 315-218-7466 |
Mrs. Hilary Cynthia Kuper Usiatynski, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 170 Intrepid Lane, High Peaks Rehab., Syracuse, NY 13205 Phone: 315-492-8319 Fax: 315-492-3758 |
Miss Karen Ann Dinse Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2707 Court St, Syracuse, NY 13208 Phone: 315-455-7571 Fax: 315-455-7573 |
Aletha Dalton Mott Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 171 Intrepid Ln, Syracuse, NY 13205 Phone: 315-437-4689 |
Julianna Maiorano, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-2308 |
Ms. Kathleen Elizabeth Gillen, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 643 Stinard Ave, Syracuse, NY 13207 Phone: 315-382-8548 |
Ann K Libera, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 S Crouse Ave, Syracuse, NY 13244 Phone: 315-443-5761 Fax: 315-443-4413 |
Mrs. Margot Jean Floch, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 W Kennedy St, Syracuse, NY 13205 Phone: 315-435-4276 |
Ashley Marie Stone, B.A., M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1744 W Genesee St, Syracuse, NY 13204 Phone: 315-468-3414 |
Dr. Jonathan L Preston, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 621 Skytop Rd, Suite 1200, Syracuse, NY 13244 Phone: 315-443-3143 |
Mrs. Joy Wyman, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1744 W Genesee St, Syracuse, NY 13204 Phone: 315-468-3414 |
Valerie Sager, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St # 2104, Syracuse, NY 13210 Phone: 315-464-5820 |
Victoria Abramson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1951 Caleb Ave, Syracuse, NY 13206 Phone: 315-218-7444 Fax: 315-218-7466 |
Megan Putnam Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1951 Caleb Ave, Syracuse, NY 13206 Phone: 315-218-7444 |
News Archive
A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which glioblastoma, the most common kind of brain cancer, evades targeted therapies. Published in the current issue of the journal Science, the paper describes how GBM tumor cells essentially hide the signaling molecule targeted by such therapies, adding a layer of complexity to current models of drug resistance in cancer.
Van Andel Research Institute researchers have found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against clear cell renal cell carcinoma (ccRCC), a deadly form of kidney cancer. Most patients who show a positive response to sunitinib develop a resistance to the drug after one year of treatment.
A team of Massachusetts General Hospital investigators has discovered a new combination of drugs that may be effective against one of the deadliest cancers, malignant melanoma. The combination - pairing a drug targeted against mutations in the BRAF gene with a second drug that targets another important signaling pathway - was discovered through one of the largest screens of cancer drug combinations conducted to date.
A nurse-directed initiative to examine the root causes of hypoglycemic episodes resulted in a sustained reduction in hypoglycemia among critically ill patients at Stamford Hospital in Connecticut, according to a study published in the August issue of Critical Care Nurse.
Safeway Inc. announced today it has raised a record $10.2 million to support medical research and services for the millions of people living with neuromuscular diseases. The funds were raised during Safeway's annual Muscular Dystrophy Association (MDA) campaign, a five-week endeavor to highlight the need to find cures and treatments for muscular dystrophy and related diseases, and presented during the Jerry Lewis MDA Telethon in Las Vegas Labor Day weekend.
› Verified 8 days ago